The project provides a framework for the structured interaction of key opinion leaders in oncology from Asia and Europe.
Tailoring the ESMO Clinical Practice Guidelines to the local context results in a resource-efficient, valuable tool that can be used by health professionals and patients to harmonise optimal, evidence-based practice across Asia, focus on ethnic differences and potentially approach regulatory authorities.
Started in 2017 as a collaboration between ESMO and the Japanese Society of Medical Oncology (JSMO), the PAGA project has grown and flourished with the active collaboration of the oncology societies of China (CSCO), India (ISMPO), Indonesia (ISHMO), Japan (JSMO), South Korea (KSMO), Malaysia (MOS), Philippines (PSMO), Singapore (SSO), Taiwan (TOS), and Thailand (TSCO). Every year, Asian experts from these collaborating societies engage in productive scientific interactions with their European counterparts to build consensus towards Pan-Asian adaptation of three to four ESMO Clinical Practice Guidelines, which are then published in ESMO Open and presented at the ESMO Asia Congress.